Ask your doctor about a second indication for ILUVIEN
Talk to your eye doctor about the risks associated with ILUVIEN.
In clinical trials, the MOST COMMON adverse reactions reported were:
Development of cataracts or clouding of the lens (82% (192 of 235) of ILUVIEN treated patients; control group 50%)?In clinical trials, sham group is used as a comparator and receives similar treatment including the operative procedure without the therapeutic part.
Increased eye pressure (ILUVIEN 34%; control group 10%) ?In clinical trials, sham group receives similar treatment including the operative procedure without the therapeutic part.
Endophthalmitis – In the days following the administration of ILUVIEN into the eye, you are at risk for the development of endophthalmitis (a serious eye infection).
Retinal detachment – Intravitreal injections, including those with ILUVIEN, have been associated with retinal detachment.
Temporary blurred vision – You may experience temporary visual blurring after receiving ILUVIEN.